SEC Form 4 · accession 0001209191-15-028200
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Sachdev
Officer — EVP, Policy, Access & Value
Period of report
Mar 18, 2015
Accepted (ET)
Mar 20, 2015 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 18, 2015 | M | 5,375 | $39.05 | A | 95,359 | D | |
| Common Stock | Mar 18, 2015 | M | 6,625 | $45.11 | A | 101,984 | D | |
| Common Stock | Mar 18, 2015 | S | 12,000 | $130.00 | D | 89,984 | D | |
| Common Stock | holding | — | — | — | 882 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $39.05 | Mar 18, 2015 | M | 5,375 | D | — | Feb 3, 2020 | Common Stock | 5,375 | 0 | D |
| Stock Option (right to buy)F3 | $45.11 | Mar 18, 2015 | M | 6,625 | D | — | Feb 4, 2023 | Common Stock | 6,625 | 39,125 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
- F2Fully vested.
- F3The option vests in 16 quarterly installments from 02/05/2013.